targeting tumour drivers and resistance
Published 4 years ago • 1.2K plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
0:58
molecular glues: targeting intractable proteins
-
2:20
ask a scientist: treating disease earlier
-
3:44
what is a driver mutation?
-
4:31
your lung cancer healthcare team
-
8:02
how close are we to a cure for lung cancer? #science #cancer
-
5:15
lung cancer treatment
-
34:45
krishna bulusu - knowledge graphs for target discovery and precision oncology at astrazeneca
-
1:07:38
oig-abg lect 12 -"insights into tumour biology and drug targeting using intravital imaging”
-
0:42
targeting programmed cell death to transform cancer therapies
-
2:29
combining crispr and ai to accelerate cancer drug discovery
-
1:08:39
ecological interactions drive evolution of targeted therapy resistance in cancer
-
3:39
tumor-related immune checkpoints and the development of targeted cancer immunotherapies
-
14:48
business brief: david fredrickson, evp, oncology business unit, astrazeneca
-
1:15
computational pathology: revolutionising cancer therapies and diagnostics
-
3:38
uncovering the oncology revolution
-
2:16
the top-searched questions on cancer and covid-19
-
10:02
industry view of targeted therapy combinations in oncology
-
1:13
new normal same cancer
-
1:25
new normal, same cancer – don’t wait
-
1:10:49
targeting cancer pathways: tumor resistance
-
7:29
your treatment options after a lung cancer diagnosis